Abstract:Extracellular vesicles (EVs) have emerged as important carriers for intercellular communication and biological sources for diagnosis and therapeutics. Low efficiency in EV isolation from biofluids, however, severely restricts their downstream characterization and analysis. Here, we introduced a novel strategy for EV isolation from urine for prostate cancer diagnosis using bifunctionalized magnetic beads through high affinity Ti(IV) ions and the insertion of a phospholipid derivative, 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine, into the EV membrane synergistically. We demonstrated its efficient isolation of EVs from urine samples with low contamination, high recovery (>80%), and short separation time (within 1 h), resulting in the identification of 36,262 unique EV peptides corresponding to 3302 unique proteins and 3233 unique phosphopeptides representing 1098 unique phosphoproteins using only 100 μL and 5 mL urine samples, respectively. Coupled with trapped ion mobility spectrometry and parallel accumulation–serial fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics of urine samples from prostate cancer patients and healthy individuals revealed 121 upregulated phosphoproteins in cancer patients in contrast to the healthy group. These particular advantages indicate that the novel bifunctional material enables sensitive EV phosphoproteomic analysis for noninvasive biomarker screening and early cancer diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19400</a>.FTIR, zeta potential, and fluorescence characterization of the different MBs-based materials (Figure S1); size distribution characterization of EVs isolated using UC, TiMBs, and DspeMBs (Figure S2); whole proteome overlap among different methods and top proteins of exosome and the phosphopeptides analysis of different isolation methods (Figure S3); Pearson correlation of EV proteomes of the clinical urine samples (Figure S4); the interaction pathway of the upregulated phosphoproteins (Figure S5); fold increase in these 13 exosomal proteins and 3 free urine proteins from LC–MS data of different methods compared to the UC sample (Table S2); and the list of the cancer-associated upregulated phosphoproteins (Table S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_001.pdf">PDF</a>)LC–MS whole proteome analysis data of EVs isolated by different methods (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_002.xlsx">XLSX</a>)LC–MS phosphoproteome analysis data of EVs isolated by different methods (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_003.xlsx">XLSX</a>)LC–MS prostate cancer-specific EV phosphoproteins analysis data (Table S4) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_004.xlsx">XLSX</a>)Mobility resolution of phosphorylation site isomers in urine EVs from prostate cancer patients (Table S6) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_005.xlsx">XLSX</a>)This article has not yet been cited by other publications.

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis

Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics

Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles Through Automated and High-Throughput Isolation.

Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis

Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification

High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer

Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study

An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.

Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery

Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.

UPCARE: Urinary Extracellular Vesicles-Derived Prostate Cancer Assessment for Risk Evaluation

One-Pot Sequential Enrichment of Urinary Extracellular Vesicle and miRNAs Identifies a Noninvasive Biomarker Panel for Prostate Cancer Diagnosis

Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

Nanomaterials-Based Urinary Extracellular Vesicles Isolation and Detection for Non-invasive Auxiliary Diagnosis of Prostate Cancer

Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays

Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs

Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer

Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis

Prostate-Specific Membrane Antigen (PSMA)-Positive Extracellular Vesicles in Urine—A Potential Liquid Biopsy Strategy for Prostate Cancer Diagnosis?

Membrane Feature-Inspired Profiling of Extracellular Vesicles for Pancreatic Cancer Diagnosis.

Hands-Free Proteomic Profiling of Urinary Extracellular Vesicles with a High-Throughput Automated Workflow